Read early research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on quitting smoking and lung cancer survival, recurrent ovarian cancer treatment, geriatric assessment for patients receiving systemic therapy, how Medicaid expansion is impacting U.S. cancer mortality, and using videoconferencing with long-distance caregivers. Read More >>
lung cancer
May 13, 2020 · Leslie Fannon Zhang, ASCO staff
May 13, 2020 · Leslie Fannon Zhang, ASCO staff
Lea los puntos destacados iniciales de la investigación del programa científico virtual ASCO20 que se acaban de publicar. Estos incluyen estudios sobre dejar de fumar y la supervivencia al cáncer de pulmón, el tratamiento del cáncer de ovario recurrente, la evaluación geriátrica para los pacientes que están recibiendo terapia sistémica, cómo la ampliación de Medicaid afecta a la mortalidad por cáncer en EE. UU. y el uso de videoconferencias con los cuidadores a distancia. Read More >>
November 21, 2019 · Navneet Singh, MD, DM, FRCP (London)
Dr. Navneet Singh explains cancer care limitations in India and how a new national health care program may improve access to treatment. Read More >>
November 14, 2019 · Greg Guthrie, ASCO staff
Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment. Read More >>
October 17, 2019 · Claire Smith, ASCO staff
In this podcast, Dr. Vamsidhar Velcheti discusses an early study on a new targeted therapy for non-small cell lung cancer. Read More >>